FastSize LLC Release: Leading Researcher To Test European Peyronie’s Device

ALISO VIEJO, Calif., June 5 /PRNewswire/ -- Leading American Urologist Dr. Laurence Levine, of Urology Associates in Chicago, is about to embark upon a "proof of concept" medical trial to investigate the use of traction therapy (FastSize) in the treatment of Peyronie's Disease. The disease results in unnatural bends in penile tissues that can range from mild to totally debilitating. It affects an estimated 9-12 percent of all American males.

The therapy is already widely used in Europe where studies and published papers have shown excellent success rates. Medical traction devices designed to deliver this therapy have been "CE" marked in Europe -- a standard of manufacture and performance that meets government approval.

Levine, recognized as an authority on Peyronie's Disease, has followed the development of traction therapy treatment in Europe and late last year decided to see if European trial results could be duplicated in the US. Levine obtained sponsorship for the study from FastSize LLC, a California-based manufacturer of the European style traction therapy device. Called the FastSize Extender, the device can also be used as a non-surgical treatment for penile enlargement. As a result, Levine has organized a pilot study that is now about to get under way. The study will be a formal clinical trial under Institutional Review Board guidelines and may be the precursor to a larger trial next year.

The study will make its results known later this year through medical publications and via the FastSize website. Until the introduction of the FastSize Extender into the US last year, there were few treatments available for Peyronie's Disease. Promising results have been obtained from the off- label use of a three-cylinder vacuum therapy device designed for the treatment of erectile dysfunction (ED). Now the Extender, especially with its successful history in Europe, provides another option to patients with the debilitating disease.

Dr. Levine is scheduled to make introductory remarks about the trial at lectures to be delivered at the annual convention of the American Urological Association late in May of this year in Atlanta, Ga.

FastSize LLC

CONTACT: Scott Hays of FastSize LLC, +1-949-306-3290, Shays@FastSize.com

MORE ON THIS TOPIC